#United States #Chicago #RSNA 2024 #RaySearch Labs #Liver Ablation

RaySearch Technologies to Highlight Liver Ablation Advances at RSNA 2024

RaySearch Laboratories is gearing up to showcase its innovative software solutions at the Radiological Society of North America (RSNA) annual meeting, which will occur in Chicago, Illinois, from December 1 to 4, 2024. This event, renowned as the largest conference in the realm of radiology, presents a pivotal moment for RaySearch to demonstrate its commitment to enhancing liver ablation treatments through advanced technology.

Transformative Solutions for Liver Ablation

At RSNA, attendees will have the opportunity to explore RaySearch's new liver ablation module, featuring a suite of sophisticated tools designed to streamline and enhance treatment processes. This module includes capabilities like automatic structure segmentation using deep learning algorithms, virtual applicator placement, and accurate estimation of the ablation zone. Additionally, it offers applicator placement verification and post-treatment verification based on deformable registration techniques, ensuring precision and effectiveness in procedures.

Engage with Cutting-Edge Research at RSNA

In addition to product demonstrations at booth #8340, RaySearch is hosting a special session focused on interventional radiology. Dr. Bruno C. Odisio from the MD Anderson Cancer Center will present groundbreaking findings from the COVER-ALL study. This randomized trial investigates the efficacy of a novel confirmation method for ablation through biomechanical deformable image registration paired with AI-based autosegmentation, focusing on its influence on minimal ablative margins.

The session is scheduled for December 3rd, 2024, from 9:30 to 10:30 AM CST in Room N227B, marking a significant component of RSNA’s educational offerings this year.

Innovations Beyond Radiation Therapy

RaySearch will also highlight its comprehensive range of solutions, including the RayStation® treatment planning system, RayCare® oncology information system, and the innovative cloud-based analytics solution, RayIntelligence®. A new feature, DrugLog®, will also be presented. DrugLog is an independent system designed to minimize compounding errors by verifying the identity and concentration of injectable medications prior to administration, ultimately enhancing patient safety and treatment efficacy.

Johan Löf, RaySearch's founder and CEO, expressed his enthusiasm about the upcoming event: "We are eager to connect with both our existing and potential clients at RSNA and showcase our latest research on liver ablation, alongside our diverse product offerings. The introduction of DrugLog signifies an expansion of our portfolio beyond just radiation therapy."

About RaySearch Laboratories

Founded in 2000 as a spin-off from the prestigious Karolinska Institute in Stockholm, RaySearch Laboratories AB (publ) has developed into a frontrunner in medical technology, specifically in the field of oncology. The company's advanced software solutions are in use at over 1,000 clinics across 43 countries, and its products include not only RayStation but also RayCare and RayIntelligence, which collectively enhance cancer treatment protocols.

With shares listed on Nasdaq Stockholm since 2003, RaySearch remains dedicated to pushing the boundaries of cancer care through technology and research. Interested parties can learn more about RaySearch and its offerings by visiting their website at raysearchlabs.com.

The upcoming RSNA conference represents not just a showcase of technology, but a beacon of hope for future cancer treatments, highlighting the critical role of innovation in expanding therapeutic possibilities.